donation
To request Mental Health
Services or to access Mental
Health Crisis Services Call:
1-800-375-4357

Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Almost 13 Million Americans Per Year Skip Meds Due to CostAssistance Dogs Bring Big Boost to Deaf PeopleCDC to Toughen COVID Testing for International TravelersOld Spice, Secret Antiperspirants Recalled Due to BenzeneClinical Trials Are Becoming More Diverse, But There's Still Work To DoRural Hospitals' ERs Just as Effective as Urban Ones: StudyKraft Recalls Powdered Drinks Over Metal, Glass ConcernsVials Found in Lab Contained Vaccine, not Smallpox Virus: CDCAdvances in Care, Impact of COVID Highlights of Latest Cardiologists' MeetingAcross America, Black People Have Worse Health OutcomesVials With Smallpox Labels Found at Vaccine Lab in Pennsylvania: CDCWhite House to Spend Billions to Boost COVID Vaccine SupplyAHA News: Health Class May Influence Heart Risk in South AsiansPfizer COVID Pill to Be Made, Sold Cheaply in 95 Poor CountriesFederal Court Backs Stay on COVID Vaccine Mandate for Large BusinessesMore Than 2 Million COVID Home Test Kits Recalled Due to False Positive ResultsIn Canada, Ban on Menthol Cigarettes Had More Smokers QuittingOklahoma Supreme Courts Overturns $465 Million J & J Opioid RulingPandemic Puts 'Outdated' Infection Control Practices Under ScrutinyMillions of Tons of COVID Masks, Gloves Will End Up in OceansSales of Unproven, Unapproved Stem Cell Therapies Are BoomingCourt Temporarily Blocks Biden’s Vaccine Mandate for Big BusinessesU.S. Reopens Borders to Vaccinated Foreign TravelersIt's Time to Replace Your Smoke Alarm BatteriesAHA News: How Doctors Can Help Their Patients Make Heart-Healthy Lifestyle ChangesWhite House Sets Jan. 4 Deadline for Large, Private U.S. Companies to Mandate VaccinesHepatitis B Shots Advised for All U.S. Adults Under 60Supply Chain Issues Bring Shortages of Drugs, Devices to U.S. HospitalsMedicare Could Negotiate Drug Prices Under Democrat ProposalWe've Been Here Before: How Polio Vaccine Rollout Saved Millions of Young LivesAlmost 1 in 3 U.S. Seniors Now Sees at Least 5 Doctors Per YearLanguage Can Make the Difference Between Home, Hospital Care: StudyAttorneys General Warn About Pot Products That Look Like Halloween TreatsCDC Lowers Threshold for Lead Poisoning in Youngest KidsStronger Breast Implant Safety Measures Announced by FDAWalmart Recalls Room Spray for Rare Bacteria That Sickened 4, Killing 2U.S. Gun Violence Rates Jumped 30% During PandemicMandates, Not Recommendations, Work Best to Get Folks Vaccinated: StudyU.S. Has Shared 200 Million Shots With Other CountriesLittle Change Seen in Americans' Use of Mental Health Services During PandemicWomen Doctors Face Higher Levels of Harassment, Frustration: SurveyEPA Plans New Strategy Against PFAS 'Forever Chemicals'State Spending on Poverty Really Pays Off for Kids: StudyState Lotteries Didn't Help Boost Vaccination RatesVaccinated Foreign Travelers Can Enter United States Beginning Nov. 8Despite Pressures of Pandemic, U.S. Nursing School Enrollment ClimbsBiden Administration to Invest $100 Million to Ease Health Worker ShortageFDA Warns Against Using At-Home Dermal Filler 'Pens'Death Threats, Trolling Common for Scientists Who Speak to Media About COVID'Extreme Heat' Days Have Tripled Since 1980s, and More Are Coming
Questions and AnswersLinksBook Reviews
Related Topics

Health Insurance
Healthcare

U.S. to Buy $1 Billion Worth of Rapid COVID Tests

HealthDay News
by Robert Preidt and Robin Foster
Updated: Oct 6th 2021

new article illustration

WEDNESDAY, Oct. 6, 2021 (HealthDay News) -- The Biden administration said Wednesday that it plans to purchase $1 billion worth of rapid, at-home coronavirus tests and take other actions to quadruple the number of tests available to Americans by December.

By the end of the year, the number of at-home tests should increase to 200 million a month, according to the White House, which will also expand the number of pharmacies in the federal government's free testing program to 20,000, an administration official told the Washington Post.

Increasing access to rapid tests is long overdue, public health experts said.

"This is a big deal," Scott Becker, chief executive officer of the Association of Public Health Laboratories, told the Post. "The White House is beginning to take testing as seriously as they've taken vaccinations."

In recent months, many Americans have reported difficulty getting testing appointments or buying at-home tests, according to the Post.

"These tests are cheap to make -- and there's a lot of demand for it out there," Dr. Ashish Jha, dean of the Brown University School of Public Health, told the Post. "The reason the market hasn't worked is because the [U.S. Food and Drug Administration] has made it very difficult for these tests to get out into the marketplace."

One testing advocate said approvals of rapid tests are not coming fast enough.

"This slow trickle of [emergency authorizations] is all but promising to get us a large supply of rapid tests just in time for them to no longer be as effective against Delta," Dr. Michael Mina, a Harvard University epidemiologist who has advocated for at-home testing, told the Post. "There are amazing tests produced in the billions that simply don't exist here in the U.S."

FDA officials have said they are concerned that the rapid tests are less accurate than the slower PCR tests that need to be evaluated in a laboratory and can take days to produce results. On Wednesday, the Australian company Ellume recalled roughly 195,000 of its at-home coronavirus rapid tests after discovering an increased chance that the affected kits would return false positive results.

More information

Visit the U.S. Food and Drug Administration for more on COVID testing.

SOURCE: Washington Post